The smallpox vaccine left a scar because it worked by creating a genuine, localized skin infection with a live virus. Unlike most modern vaccines, which are injected into muscle and provoke an immune response without visible damage, the smallpox vaccine was deliberately scratched into the top layers of skin using a special needle, and the live vaccinia virus it contained replicated at that spot over a period of weeks. The resulting blister, scab, and tissue destruction left behind a round, pitted mark that most recipients carried for life. That scar was not an accident or side effect; for much of the twentieth century, it was treated as proof that the vaccination had worked.
How the Vaccine Was Delivered
The scarification method used for smallpox vaccination was unusual compared to how we think of shots today. Rather than a syringe pushing liquid into muscle, a healthcare worker dipped a two-pronged instrument called a bifurcated needle into a droplet of vaccine and then jabbed it into the skin of the upper arm repeatedly, usually fifteen times in rapid succession within a small area. Each jab punctured just the outer layers of skin, creating tiny wounds through which the live vaccinia virus could enter. This technique, known as multiple puncture, became the standard approach during the global eradication campaign and replaced older methods that had used lancets, knives, and even forks over the centuries.
The choice of this delivery route was not arbitrary. Scarification deposited the virus directly into the epidermis and dermis, where it encountered a dense network of immune cells. Research in animal models has shown that this route reliably produces a visible lesion at the vaccination site, whereas injecting the same vaccine into muscle does not produce any observable skin lesion at all.1PubMed Central. Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model The skin reaction was, in a sense, the point. Historical vaccination practices actually originated from a method called variolation, in which material from a smallpox patient was deliberately introduced through a cut in the forearm. When Edward Jenner replaced smallpox material with the milder cowpox virus, the skin-based delivery method carried over.2The Korean Association for the Social History of Medicine. The Development of the Vaccination and Medical Technology in Korea: Transition From Variolation to Cowpox Vaccine and Gap between Medical Knowledge and Technology The bifurcated needle, developed in the 1960s, simply refined this centuries-old approach into something faster and more standardized, which proved critical for mass vaccination campaigns across the globe.3PubMed. Smallpox vaccination techniques; from knives and forks to needles and pins
What Happened at the Vaccination Site
Once the vaccinia virus entered the skin, it began replicating in local cells, triggering a dramatic sequence of events over about three weeks. Within a few days, a small red bump appeared. By the end of the first week, it had grown into a raised, fluid-filled blister called a vesicle. During the second week, the blister became a larger, pus-filled pustule surrounded by a wide ring of redness and swelling. The area was often tender and warm to the touch, and many people experienced fever, fatigue, and swollen lymph nodes. By the third week, the pustule began drying into a thick scab. When the scab finally fell off, it left behind a depressed, pale, sometimes irregular patch of skin.
The tissue damage that produced the scar was a direct consequence of the battle between the virus and the immune system. Vaccinia virus replicates in skin cells and destroys them in the process. The immune system responds with a powerful inflammatory assault, flooding the area with immune cells that kill infected tissue.4PLoS Pathogens. Locally Produced IL-10 Limits Cutaneous Vaccinia Virus Spread This coordinated response is effective at clearing the virus, but it also damages the surrounding skin in the crossfire. The body simultaneously produces anti-inflammatory signals to try to limit collateral damage, but the infection site still sustains enough destruction that normal skin architecture cannot fully regenerate. What grows back is scar tissue rather than normal skin, leaving the characteristic pitted or raised mark.
Animal studies have confirmed this basic picture: skin inoculation with vaccinia virus produces measurable lesions, and virus can be recovered from the site throughout the active infection period.5PubMed Central. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir The depth and intensity of the local infection explain why the scar was so lasting. Unlike a shallow cut or a needle poke, the vaccinia lesion destroyed tissue across multiple layers of skin, similar to how a deep burn leaves a permanent mark.
Why the Scar Was Considered a Good Sign
For the doctors and public health workers who administered billions of smallpox vaccinations over the twentieth century, the appearance of that pustule and eventual scar was not just expected but actively sought. They called a successful reaction a “take.” If the vaccination site developed the full sequence of redness, blistering, pustule, and scab, the vaccine had taken, and the person was considered protected. If no lesion developed, the vaccination was assumed to have failed, and the person was revaccinated.
This made the scar an extraordinarily practical public health tool. In an era without electronic health records, and in remote communities without reliable documentation, a quick look at someone’s upper arm could confirm whether they had been vaccinated. During the global eradication campaign, field workers relied on scar checks to identify who still needed vaccination. The scar was, in effect, a permanent medical record written on the body.6PubMed Central. Impaired Innate, Humoral, and Cellular Immunity Despite a Take in Smallpox Vaccine Recipients
There is an important caveat, though. Research has shown that having a visible scar does not always guarantee a person developed a robust, lasting immune response. Some vaccinated individuals who had a perfectly normal-looking take still showed impaired immune markers when tested later. The take and scar are readily recognizable, but a typical vaccine take may not always equate to a fully protective immune response.6PubMed Central. Impaired Innate, Humoral, and Cellular Immunity Despite a Take in Smallpox Vaccine Recipients Despite that limitation, the scar-based system worked well enough to help eradicate smallpox entirely by 1980.
Why Some People Got Bigger or More Dramatic Scars
Not everyone walked away with the same tidy round dent on their arm. Some people developed small, barely noticeable marks, while others had large, irregular, or raised scars that drew attention for the rest of their lives. Several factors influenced how the scar turned out.
The vaccination technique itself mattered. If the person administering the vaccine jabbed too vigorously, used too many punctures, or scratched a wider area than necessary, the resulting lesion and scar could be larger. Different eras and different countries used slightly different instruments and protocols, which contributed to the variety of scars people carry today.
Individual healing biology also played a major role. Some people are genetically prone to forming keloids, which are thick, raised scars that grow beyond the boundaries of the original wound. Keloids after smallpox vaccination have been documented, and they are more common in people with darker skin and in those with a family history of keloid formation.7PubMed. Extensive keloid formation and progression after each vaccination For these individuals, the scar could be not just larger but actively uncomfortable, sometimes itching or becoming tender years after the vaccination.
Age at vaccination mattered too. People vaccinated as infants or young children tended to develop smaller scars than adults, partly because the immune response in young children is somewhat different and partly because the vaccination site simply had less skin area to work with. Revaccination, which was common for military personnel and healthcare workers, sometimes produced a milder reaction the second time because the immune system recognized the virus more quickly and limited local damage. But in some cases, revaccination could still leave an additional scar or enlarge the first one.
In rare cases, the local reaction could become genuinely dangerous. Complications like progressive vaccinia, where the lesion continued to grow rather than heal, or generalized vaccinia, where virus spread beyond the vaccination site, were documented, though these severe outcomes were uncommon.8PubMed. Generalized vaccinia, progressive vaccinia, and eczema vaccinatum are rare following smallpox (vaccinia) vaccination: United States surveillance, 2003 People with eczema or weakened immune systems were at heightened risk of these complications, which is part of why smallpox vaccination was eventually restricted rather than given universally once the disease was eliminated.
How Long Did the Protection Behind the Scar Actually Last
One of the more remarkable aspects of the smallpox vaccine is how long its protection persisted. The scar might fade slightly over the decades, but the immune memory it represented could last a lifetime. A longitudinal study measuring antibody levels in vaccinated individuals found that vaccinia-specific neutralizing antibodies remained stable for up to 88 years after vaccination. Even people who had received only a single dose maintained protective levels of these antibodies essentially indefinitely, with the decline in antibody levels over time being so small as to be almost immeasurable.9PubMed Central. Immunity from Smallpox Vaccine Persists for Decades A Longitudinal Study
Memory B cells, the immune cells responsible for quickly ramping up antibody production if the body encounters the virus again, have been detected more than 50 years after vaccination. These cells don’t circulate in huge numbers, making up roughly 0.1 percent of circulating antibody-producing B cells, but they remain functional. When researchers revaccinated people decades after their first dose, these memory cells mounted a rapid, strong antibody response.10PubMed. Cutting edge: long-term B cell memory in humans after smallpox vaccination Virus-specific helper T cells, another arm of the immune system, were also detectable decades later.
This exceptional durability is part of what made smallpox eradication possible. Vaccinated individuals stayed protected for so long that even with imperfect coverage, the virus ran out of susceptible hosts. It also means that many people alive today who were vaccinated before routine smallpox vaccination ended in the 1970s or early 1980s likely still carry some degree of immunity, though exactly how much protection that older vaccination provides against related viruses like mpox is still debated.
The BCG Scar and Why It Looks Similar
If you have a round scar on your upper arm and are not sure whether it came from a smallpox vaccine or a BCG vaccine (for tuberculosis), you are in good company. The two scars look similar for a reason: both vaccines use live pathogens delivered into the skin, and both produce a localized infection that heals into a permanent mark. The BCG scar is typically smaller and flatter than a classic smallpox scar, but in practice the two can be hard to tell apart, especially as they age.
Researchers have noted that scar formation after either vaccine serves as a marker of successful vaccination and “vaccine take,” meaning the same basic principle applied to both: if you got a scar, the vaccine likely worked.11SpringerLink (Seminars in Immunopathology). The mark of success: The role of vaccine-induced skin scar formation for BCG and smallpox vaccine-associated clinical benefits What makes both of these vaccines particularly interesting to scientists today is that both appear to have “nonspecific” or “pathogen-agnostic” benefits, meaning they seem to protect against diseases beyond the ones they were designed to prevent. BCG-vaccinated children in some studies have lower overall mortality from infections unrelated to tuberculosis, and similar observations have been made for the smallpox vaccine. How the local skin events that produce the scar relate to these broader protective effects is an active area of research that has not been fully explained.
Your birth year and country of origin usually resolve the question of which scar you have. If you were born in the United States after 1972, routine smallpox vaccination had ended, so a round upper-arm scar is almost certainly from BCG if you received it abroad or from another vaccine entirely. If you were born before that cutoff in the U.S., or in a country where smallpox vaccination continued later, the scar is more likely smallpox. Many countries continued BCG vaccination well past the end of smallpox vaccination, so people born in the 1980s and 1990s in much of the world may carry a BCG scar but not a smallpox scar.
Why Modern Vaccines Do Not Leave Scars
The absence of scarring from today’s routine vaccinations comes down to two key differences: what is in the vaccine and how it gets into the body. Modern vaccines generally use inactivated viruses, viral proteins, or mRNA instructions rather than live, replicating organisms. These components stimulate the immune system without establishing a genuine local infection. And they are injected into muscle tissue with a thin hypodermic needle, not scratched into the skin. There is no localized battle between replicating pathogen and immune cells, no tissue destruction, and therefore no scar.
Even newer smallpox-type vaccines have moved in this direction. The vaccine currently stockpiled in many countries for emergency use against smallpox or mpox (known as MVA or Modified Vaccinia Ankara) uses a version of the vaccinia virus that cannot replicate in human cells. It is injected under the skin with a conventional needle rather than scratched in. It produces no lesion and no scar. This is safer and more comfortable, but it also means losing the scar as a built-in verification tool. Confirming vaccination now depends on medical records or electronic databases rather than a visual check.
The trade-off is generally considered worthwhile. The smallpox scar was a useful feature in the context of a global eradication campaign, especially in areas without strong medical infrastructure. But the same intense local reaction that produced the scar also caused pain, swelling, and days of discomfort for every recipient, and serious complications for a small number. Moving away from scarification reflects the broader trend in vaccine development toward triggering immunity with the least amount of collateral damage.
Where the Scars Are Now
Billions of people worldwide still carry smallpox vaccine scars, though the population is aging. Routine civilian vaccination ended in the United States in 1972, in the United Kingdom in 1971, and in most other countries by the early 1980s after the World Health Organization declared smallpox eradicated. Military personnel in several countries continued receiving the vaccine somewhat longer. A modeling study estimated that vaccination coverage varies substantially across the globe, ranging from about 7 to 60 percent within subnational regions, with the variation driven mostly by differences in local demographics and the timing of when each country stopped vaccinating.12Lancet Infect Dis. The global landscape of smallpox vaccination history and implications for current and future orthopoxvirus susceptibility: a modelling study
For the generations who carry the mark, the scar serves as a tangible connection to one of the greatest public health achievements in history. It is a record of an immune event so vigorous that it left a physical trace decades later, a small crater on the upper arm that tells the story of a world that once feared a disease capable of killing roughly a third of those it infected. The virus is gone; the scars remain.